What is the share price of Sampre Nutritions Ltd (SAMPRE) today?
The share price of SAMPRE as on 4th November 2026 is ₹4.20. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Sampre Nutritions Ltd (SAMPRE) share?
The past returns of Sampre Nutritions Ltd (SAMPRE) share are- Past 1 week: -15.49%
- Past 1 month: -31.60%
- Past 3 months: -14.81%
- Past 6 months: -75.44%
- Past 1 year: -88.35%
- Past 3 years: -71.33%
- Past 5 years: -13.58%
What are the peers or stocks similar to Sampre Nutritions Ltd (SAMPRE)?
The peers or stocks similar to Sampre Nutritions Ltd (SAMPRE) include:What is the market cap of Sampre Nutritions Ltd (SAMPRE) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Sampre Nutritions Ltd (SAMPRE) is ₹39.90 Cr as of 4th November 2026.What is the 52 week high and low of Sampre Nutritions Ltd (SAMPRE) share?
The 52-week high of Sampre Nutritions Ltd (SAMPRE) is ₹38.95 and the 52-week low is ₹4.16.What is the PE and PB ratio of Sampre Nutritions Ltd (SAMPRE) stock?
The P/E (price-to-earnings) ratio of Sampre Nutritions Ltd (SAMPRE) is 12.96. The P/B (price-to-book) ratio is 0.37.Which sector does Sampre Nutritions Ltd (SAMPRE) belong to?
Sampre Nutritions Ltd (SAMPRE) belongs to the Consumer Staples sector & FMCG - Foods sub-sector.How to buy Sampre Nutritions Ltd (SAMPRE) shares?
You can directly buy Sampre Nutritions Ltd (SAMPRE) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Sampre Nutritions Ltd
SAMPRE Share Price
BSE₹4.200.71% (-0.03)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max
SIP
SAMPRE Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
AvgCan be considered moderately valued vs the market
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
SAMPRE Performance & Key Metrics
SAMPRE Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 11.18 | 0.37 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.00 | 7.30 | 1.90% |
SAMPRE Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
SAMPRE Company Profile
Sampre Nutritions Limited is an Indian company engaged in the manufacturing of sugar candies. It specializes in sugar boiled candies and toffees, offering a range of confectionery products for both domestic and export markets. Key products include Eclairs, Candy Nutri, and Just Toffy.
NESTLEIND
PE Ratio
70.65
70.65
1Y Return
2.14%
2.14%
Buy Reco %
65.63
65.63
BRITANNIA
PE Ratio
47.03
47.03
1Y Return
16.25%
16.25%
Buy Reco %
72.73
72.73
PE Ratio
50.71
50.71
1Y Return
36.20%
36.20%
Buy Reco %
100.00
100.00
HATSUN
PE Ratio
65.42
65.42
1Y Return
0.99%
0.99%
Buy Reco %
50.00
50.00
MILKYMIST
PE Ratio
183.38
183.38
1Y Return
66.39%
66.39%
Buy Reco %
100.00
100.00
SAMPRE Forecast
SAMPRE Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
SAMPRE
SAMPRE
Income
Balance Sheet
Cash Flow
Quarterly Normal View
SAMPRE Income Statement
SAMPRE Income Statement
Quarterly Normal View
| Quarter | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | jun 2026 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 4.85 | 4.54 | 7.27 | 5.62 | 8.07 | 10.89 | 10.00 | 7.39 | 15.77 | 14.92 | ||||||||||
Operating & Other expenses | 2.73 | 3.55 | 6.26 | 5.14 | 14.03 | 9.48 | 8.05 | 5.90 | 14.67 | 13.35 | ||||||||||
EBITDA | 2.12 | 0.99 | 1.01 | 0.48 | -5.96 | 1.41 | 1.95 | 1.49 | 1.10 | 1.57 | ||||||||||
| Depreciation/Amortization | 0.92 | 0.44 | 0.44 | 0.44 | 0.66 | 0.39 | 0.61 | 0.50 | 0.54 | 0.51 | ||||||||||
| PBIT | 1.20 | 0.55 | 0.57 | 0.04 | -6.62 | 1.02 | 1.34 | 0.99 | 0.56 | 1.06 | ||||||||||
| Interest & Other Items | 0.48 | 0.45 | 0.45 | 0.59 | 0.58 | 0.31 | 0.28 | 0.26 | 0.51 | 0.26 | ||||||||||
| PBT | 0.72 | 0.10 | 0.12 | -0.55 | -7.20 | 0.71 | 1.06 | 0.73 | 0.05 | 0.80 | ||||||||||
| Taxes & Other Items | 0.26 | 0.00 | 0.00 | 0.00 | 0.15 | 0.00 | 0.17 | 0.10 | -1.30 | 0.10 | ||||||||||
| Net Income | 0.46 | 0.10 | 0.12 | -0.55 | -7.35 | 0.71 | 0.89 | 0.63 | 1.35 | 0.70 | ||||||||||
| EPS | 0.16 | 0.03 | 0.05 | -0.08 | -0.88 | 0.09 | 0.10 | 0.06 | 0.64 | 0.33 |
SAMPRE Company Updates
SAMPRE Stock Peers
SAMPRE Past Performance & Peer Comparison
SAMPRE Past Performance & Peer Comparison
Comparing 3 stocks from
Consumer StaplesFMCG - Foods
Compare valuation on Screener
Consumer StaplesFMCG - Foods
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Sampre Nutritions Ltd | 12.96 | 0.37 | — |
| Nestle India Ltd | 70.65 | 46.67 | 0.96% |
| Britannia Industries Ltd | 47.03 | 23.20 | 1.83% |
| Vishal Mega Mart Limited | 50.71 | 5.74 | — |
Compare valuation on ScreenerSAMPRE Stock Price Comparison
Compare SAMPRE with any stock or ETFCompare SAMPRE with any stock or ETF
SAMPRE
SAMPRE Holdings
SAMPRE Shareholdings
SAMPRE Promoter Holdings Trend
SAMPRE Promoter Holdings Trend
SAMPRE Institutional Holdings Trend
SAMPRE Institutional Holdings Trend
Increased Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has increased by 1.15%
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
SAMPRE Shareholding Pattern
SAMPRE Shareholding Pattern
SAMPRE Shareholding History
SAMPRE Shareholding History
Foreign Institutions
smallcases containing SAMPRE stock
smallcases containing SAMPRE stock
Looks like this stock is not in any smallcase yet.
SAMPRE Events
SAMPRE Events
SAMPRE Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
SAMPRE has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
SAMPRE Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
SAMPRE has not given any dividends in last 5 years
SAMPRE Dividends
SAMPRE Dividends
Hmm, looks like data is unavailable here. Please come back after some timeSAMPRE Stock News & Opinions
SAMPRE Stock News & Opinions
Articles & Videos
Corporate
Corporate
Sampre Nutritions Limited will halt securities trading October 1st pending financial resultsSampre Nutritions Limited informed the BSE Limited that it will close the trading window for dealing in securities from October 1, 2026, until 48 hours after the declaration of unaudited standalone and consolidated financial results for the second quarter of the financial year 2026-27 ending September 30, 2026.
1 month agoCapital Market - Live
Corporate
Corporate
Sampre Nutritions allocates shares worth Rs 743.7 million to Brahma and Meera GurbaniSampre Nutritions Limited announced that its board of directors approved the allotment of 1,770,710 fully paid-up equity shares with a face value of Rs 5 each at an issue price of Rs 42 each, including a premium of Rs 37 each, aggregating to Rs 7,43,69,820, to Brahma Gurbani and Meera Gurbani, upon conversion of unsecured loan.
1 month agoCapital Market - Live
Corporate
Corporate
Sampre Nutritions to review Q1 financials and director remuneration at August meetingSampre Nutritions Limited will hold a board meeting on Wednesday, August 5, 2026, to approve the unaudited standalone and consolidated financial results for the first quarter ended June 30, 2026, and to consider a proposal to increase the remuneration of Whole-Time Director Vishal Gurbani from Rs 18,00,000 per annum to Rs 60,00,000 per annum, effective April 1, 2026, subject to member approval.
3 months agoCapital Market - Live
Earnings
Earnings
Sampre Nutritions reports consolidated net profit of Rs 1.35 crore in the March 2026 quarterNet profit of Sampre Nutritions reported to Rs 1.35 crore in the quarter ended March 2026 as against net loss of Rs 7.35 crore during the previous quarter ended March 2025. Sales rose 94.34% to Rs 15.10 crore in the quarter ended March 2026 as against Rs 7.77 crore during the previous quarter ended March 2025. For the full year,net profit reported to Rs 3.08 crore in the year ended March 2026 as against net loss of Rs 7.67 crore during the previous year ended March 2025. Sales rose 72.57% to Rs 43.35 crore in the year ended March 2026 as against Rs 25.12 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales15.107.77 94 43.3525.12 73 OPM %2.85-80.69 -10.98-15.37 - PBDT0.59-6.54 LP 3.82-5.55 LP PBT0.05-7.21 LP 1.78-7.52 LP NP1.35-7.35 LP 3.08-7.67 LP Powered by Capital Market - Live
5 months agoCapital Market - Live
Earnings
Earnings
Sampre Nutritions reports consolidated net profit of Rs 0.62 crore in the December 2025 quarterNet profit of Sampre Nutritions reported to Rs 0.62 crore in the quarter ended December 2025 as against net loss of Rs 0.54 crore during the previous quarter ended December 2024. Sales rose 32.44% to Rs 7.39 crore in the quarter ended December 2025 as against Rs 5.58 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales7.395.58 32 OPM %20.167.89 - PBDT1.22-0.11 LP PBT0.72-0.54 LP NP0.62-0.54 LP Powered by Capital Market - Live
8 months agoCapital Market - Live
Corporate
Corporate
Sampre Nutritions to hold board meetingSampre Nutritions will hold a meeting of the Board of Directors of the Company on 13 February 2026.Powered by Capital Market - Live
8 months agoCapital Market - Live
Corporate
Corporate
Sampre Nutritions to hold EGMSampre Nutritions announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 10 December 2025.Powered by Capital Market - Live
11 months agoCapital Market - Live
Earnings
Earnings
Sampre Nutritions consolidated net profit rises 650.00% in the September 2025 quarterNet profit of Sampre Nutritions rose 650.00% to Rs 0.90 crore in the quarter ended September 2025 as against Rs 0.12 crore during the previous quarter ended September 2024. Sales rose 37.55% to Rs 10.00 crore in the quarter ended September 2025 as against Rs 7.27 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales10.007.27 38 OPM %19.5013.89 - PBDT1.670.56 198 PBT1.060.12 783 NP0.900.12 650 Powered by Capital Market - Live
11 months agoCapital Market - Live
Corporate
Corporate
Sampre Nutritions to hold board meetingSampre Nutritions will hold a meeting of the Board of Directors of the Company on 5 November 2025.Powered by Capital Market - Live
1 year agoCapital Market - Live
Corporate
Corporate
Sampre Nutritions to conduct board meetingSampre Nutritions will hold a meeting of the Board of Directors of the Company on 3 October 2025.Powered by Capital Market - Live
1 year agoCapital Market - Live
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant